U.S. Stem Cell, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
U.S. Stem Cell, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q4 2022.
  • U.S. Stem Cell, Inc. Common Stock, Shares, Issued for the quarter ending December 31, 2022 was 634M shares, a 26% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 634M +131M +26% Dec 31, 2022 10-K 2023-04-14
Q3 2022 632M +171M +37.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 598M +146M +32.4% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 592M +141M +31.4% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 504M +68M +15.6% Dec 31, 2021 10-K 2023-04-14
Q3 2021 461M +31.5M +7.33% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 452M +23.7M +5.55% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 450M +25.5M +6% Mar 31, 2021 10-Q 2021-07-16
Q4 2020 436M +17.8M +4.27% Dec 31, 2020 10-K/A 2022-07-08
Q3 2020 430M +32M +8.04% Sep 30, 2020 10-Q 2021-07-16
Q2 2020 428M +34.3M +8.71% Jun 30, 2020 10-Q 2021-07-16
Q1 2020 425M +35.3M +9.05% Mar 31, 2020 10-Q 2021-07-16
Q4 2019 418M +39.6M +10.5% Dec 31, 2019 10-K 2021-07-16
Q3 2019 398M +29.4M +7.99% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 394M +27.3M +7.45% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 390M +31M +8.63% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 378M +36M +10.5% Dec 31, 2018 10-K 2021-07-16
Q3 2018 368M +29M +8.55% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 366M +29.9M +8.9% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 359M +31.1M +9.5% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 342M +215M +169% Dec 31, 2017 10-K 2019-03-13
Q3 2017 339M +310M +1061% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 336M +328M +3697% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 328M +325M +11431% Mar 31, 2017 10-Q 2017-05-02
Q4 2016 127M +125M +6903% Dec 31, 2016 10-K/A 2018-04-26
Q3 2016 29.2M +28.2M +2888% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 8.86M -795M -98.9% Jun 30, 2016 10-Q 2016-08-02
Q1 2016 2.84M -668M -99.6% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 1.81M +1.23M Dec 31, 2015 10-K 2017-03-15
Q3 2015 978K -533M -99.8% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 804M +297M +58.6% Jun 30, 2015 10-Q 2015-08-03
Q1 2015 671M +250M +59.3% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 581K* -379M Dec 31, 2014 10-K 2016-03-08
Q3 2014 534M +214M +67.1% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 507M +279M +123% Jun 30, 2014 10-Q 2014-08-01
Q1 2014 421M +230M +121% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 380M +198M +109% Dec 31, 2013 10-K 2015-03-16
Q3 2013 319M +151M +90.3% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 228M +90.6M +66.1% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 190M +57.6M +43.3% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 182M +86.4M +90.4% Dec 31, 2012 10-K 2014-03-25
Q3 2012 168M +97.4M +138% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 137M +91.5M +201% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 133M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 95.6M +58.1M +155% Dec 31, 2011 10-K 2013-03-29
Q3 2011 70.5M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 45.5M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 37.5M Dec 31, 2010 10-K/A 2013-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.